Deoxy technologies: a medical technology startup project: business plan for UK market
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10071/15910 |
Resumo: | DEOXY Technologies is a seed-stage medical technology project whose future core business will be based on an innovative Gene Expression profiling (GEP) nanotechnology, developed and patented at Harvard University. The project is located at Ludwig-Maximilian University (Germany) and its goal is to develop diagnostic tests for clinical market where price, speed and automation are competitive advantages. DEOXY Technologies intends to become a global and "lean" company focused on development and manufacturing of molecular tests (in vitro medical devices). This is a strategic analysis and a feasibility study for the breast cancer market. Breast cancer is the most frequent female cancer affecting 12% of women, worldwide and is seen as a paradigm of precision medicine success. The promoter identifies a clinical application for the GEP technology and proposes an alliance with an USA biomarker-focused company whose assets are complementary to the technology. The strategic analysis was based on a macroenvironmental analysis for the entrance market: United Kingdom, where regulatory and reimbursement contexts were systematized, and for Germany the country of development and manufacturing, where the impact of governmental support and the integration in a biotechnology cluster are critical favorable factors. In the microenvironmental analysis the high barriers to entrance and the importance of planning an exit strategy were underlined. The economic and financial viability analysis revealed that governmental funding is a critical success factor, as demonstrated by the positivity of the APV and emphasized the importance of a market expansion plan before starting operations. The scenario analysis explored how reimbursement and healthcare policies may impact the economic and financial viability of the project. |
id |
RCAP_298d8a308b1d13307aae0d2588105e81 |
---|---|
oai_identifier_str |
oai:repositorio.iscte-iul.pt:10071/15910 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Deoxy technologies: a medical technology startup project: business plan for UK marketMedical devicesInnovationStrategyLean startupGestão de empresasTecnologia médicaNanotecnologiaInovaçãoAnálise estratégicaPolítica de saúdeAlemanhaReino UnidoDEOXY Technologies is a seed-stage medical technology project whose future core business will be based on an innovative Gene Expression profiling (GEP) nanotechnology, developed and patented at Harvard University. The project is located at Ludwig-Maximilian University (Germany) and its goal is to develop diagnostic tests for clinical market where price, speed and automation are competitive advantages. DEOXY Technologies intends to become a global and "lean" company focused on development and manufacturing of molecular tests (in vitro medical devices). This is a strategic analysis and a feasibility study for the breast cancer market. Breast cancer is the most frequent female cancer affecting 12% of women, worldwide and is seen as a paradigm of precision medicine success. The promoter identifies a clinical application for the GEP technology and proposes an alliance with an USA biomarker-focused company whose assets are complementary to the technology. The strategic analysis was based on a macroenvironmental analysis for the entrance market: United Kingdom, where regulatory and reimbursement contexts were systematized, and for Germany the country of development and manufacturing, where the impact of governmental support and the integration in a biotechnology cluster are critical favorable factors. In the microenvironmental analysis the high barriers to entrance and the importance of planning an exit strategy were underlined. The economic and financial viability analysis revealed that governmental funding is a critical success factor, as demonstrated by the positivity of the APV and emphasized the importance of a market expansion plan before starting operations. The scenario analysis explored how reimbursement and healthcare policies may impact the economic and financial viability of the project.A DEOXY Technologies é um projeto, baseado numa nanotecnologia inovadora de análise perfis de expressão genética (APEG), descoberta e patenteada na Universidade de Harvard. O projeto está integrado na Universidade de Ludwig-Maximilians, (Alemanha) e é candidato a fundos de investimento governamentais. A DEOXY Technologies acredita que por possuir uma tecnologia inovadora pode desenvolver máquinas de APEG e testes moleculares para o mercado clínico, onde o preço, automatização e rapidez serão vantagens competitivas. A DEOXY Technologies planeia tornar-se uma empresa global e "lean", focada no desenvolvimento e produção de testes moleculares "in vitro". Este plano de negócios contém a análise estratégica e económico-financeira para o mercado do cancro da mama, em Inglaterra (Reino Unido). O cancro da mama é o cancro mais frequente na mulher, afetando 12% desta população, e é paradigmático do sucesso da medicina de precisão. O promotor identifica uma necessidade clínica e para sua concretização propõe uma aliança com uma empresa biotecnológica detentora de ativos intelectuais complementares aos da DEOXY Technologies. A estratégia proposta baseia-se na análise PEST para o Reino Unido, contendo a regulamentação e etapas-chave para obter reembolso, e análise PEST para Alemanha, destacando-se a relevância do apoio governamental e da inserção num cluster biotecnológico como fatores críticos de sucesso. Da análise micro-ambiental salientam-se as barreiras à entrada e a importância da estratégia de saída nesta indústria. O estudo de viabilidade económico-financeira revelou que os fundos governamentais são um fator critico para a exequibilidade e viabilidade económico-financeira do projeto, sendo o valor atualizado ajustado o único indicador positivo. A análise de cenários demonstra como as políticas de cuidados de saúde influenciam a estratégia e a viabilidade económico-financeira do projeto.2018-05-24T17:50:35Z2021-05-24T00:00:00Z2016-11-28T00:00:00Z2016-11-282016-09info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfapplication/octet-streamapplication/octet-streamhttp://hdl.handle.net/10071/15910TID:201345765engHenriques, Vanessa da Silva Mouratoinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-04T01:18:47Zoai:repositorio.iscte-iul.pt:10071/15910Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:23:12.447012Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Deoxy technologies: a medical technology startup project: business plan for UK market |
title |
Deoxy technologies: a medical technology startup project: business plan for UK market |
spellingShingle |
Deoxy technologies: a medical technology startup project: business plan for UK market Henriques, Vanessa da Silva Mourato Medical devices Innovation Strategy Lean startup Gestão de empresas Tecnologia médica Nanotecnologia Inovação Análise estratégica Política de saúde Alemanha Reino Unido |
title_short |
Deoxy technologies: a medical technology startup project: business plan for UK market |
title_full |
Deoxy technologies: a medical technology startup project: business plan for UK market |
title_fullStr |
Deoxy technologies: a medical technology startup project: business plan for UK market |
title_full_unstemmed |
Deoxy technologies: a medical technology startup project: business plan for UK market |
title_sort |
Deoxy technologies: a medical technology startup project: business plan for UK market |
author |
Henriques, Vanessa da Silva Mourato |
author_facet |
Henriques, Vanessa da Silva Mourato |
author_role |
author |
dc.contributor.author.fl_str_mv |
Henriques, Vanessa da Silva Mourato |
dc.subject.por.fl_str_mv |
Medical devices Innovation Strategy Lean startup Gestão de empresas Tecnologia médica Nanotecnologia Inovação Análise estratégica Política de saúde Alemanha Reino Unido |
topic |
Medical devices Innovation Strategy Lean startup Gestão de empresas Tecnologia médica Nanotecnologia Inovação Análise estratégica Política de saúde Alemanha Reino Unido |
description |
DEOXY Technologies is a seed-stage medical technology project whose future core business will be based on an innovative Gene Expression profiling (GEP) nanotechnology, developed and patented at Harvard University. The project is located at Ludwig-Maximilian University (Germany) and its goal is to develop diagnostic tests for clinical market where price, speed and automation are competitive advantages. DEOXY Technologies intends to become a global and "lean" company focused on development and manufacturing of molecular tests (in vitro medical devices). This is a strategic analysis and a feasibility study for the breast cancer market. Breast cancer is the most frequent female cancer affecting 12% of women, worldwide and is seen as a paradigm of precision medicine success. The promoter identifies a clinical application for the GEP technology and proposes an alliance with an USA biomarker-focused company whose assets are complementary to the technology. The strategic analysis was based on a macroenvironmental analysis for the entrance market: United Kingdom, where regulatory and reimbursement contexts were systematized, and for Germany the country of development and manufacturing, where the impact of governmental support and the integration in a biotechnology cluster are critical favorable factors. In the microenvironmental analysis the high barriers to entrance and the importance of planning an exit strategy were underlined. The economic and financial viability analysis revealed that governmental funding is a critical success factor, as demonstrated by the positivity of the APV and emphasized the importance of a market expansion plan before starting operations. The scenario analysis explored how reimbursement and healthcare policies may impact the economic and financial viability of the project. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-11-28T00:00:00Z 2016-11-28 2016-09 2018-05-24T17:50:35Z 2021-05-24T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10071/15910 TID:201345765 |
url |
http://hdl.handle.net/10071/15910 |
identifier_str_mv |
TID:201345765 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/octet-stream application/octet-stream |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134793678454784 |